Physicians' Academy for Cardiovascular Education

The clinical challenges of initiating guideline recommended therapy in HF

Listen to the podcast
10' education - June 21, 2022 - Prof. John McMurray, MD - Glasgow, UK

Video navigation menu

  • The three main "concerns" with heart failure treatments 00:57
  • Clinical inertia: A tendency to do nothing or to remain unchanged 08:56
  • Therapeutic nihilism 11:51
  • Concluding remarks 13:33


Show transcript

Educational information

This lecture by prof. McMurray was part of the EBAC-accredited symposium "When to start using SGLT2i in HFrEF? Initiating guideline-recommended treatment options" held during the ESC Heart Failure 2022 congress.


Prof. McMurray is Professor of Medical Cardiology and Deputy Director (Clinical) of the Institute of Cardiovascular and Medical Sciences and honorary Consultant Cardiologist at the Queen Elizabeth University Hospital, Glasgow.


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.


Funding for this educational program was provided by an unrestricted educational grant from AstraZeneca.

View the slides of this presentation

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: